PharmaJet ®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free ...

The partners are also studying their personalized vaccine with Keytruda as an adjuvant NSCLC treatment for those who haven't gotten neoadjuvant therapy.

KEY POINTS A 35-year-old woman was admitted to a community hospital for sepsis caused by Streptococcus pyogenes bacteremia, ...

Participants also found the long-acting injectable to be feasible, acceptable and convenient. Apretude is an intramuscularly administered HIV-1 integrase strand transfer inhibitor. It works by ...